Hoth Therapeutics, Inc. (HOTH)
USD 0.69
(-12.33%)
USD 0.69
(-12.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.44 Million | -9.29 Million | -12.09 Million | -6.13 Million | -4.94 Million | -2.1 Million |
| Net Income | -7.84 Million | -11.37 Million | -14.31 Million | -7.19 Million | -7.7 Million | -2.49 Million |
| Depreciation & Amortization | - | - | - | 1043.00 | 1225.00 | 1224.00 |
| Deferred income taxes | - | - | - | -49.37 Thousand | -3664.00 | - |
| Stock-based compensation | 216.42 Thousand | 620.79 Thousand | 1.32 Million | 737.74 Thousand | 2.49 Million | 143.05 Thousand |
| Change in working capital | -748.05 Thousand | 594.47 Thousand | 529.92 Thousand | -131.75 Thousand | 169.64 Thousand | 80.45 Thousand |
| Other non-cash items | -70.08 Thousand | 858.82 Thousand | 370.83 Thousand | 506.95 Thousand | 95 Thousand | 168.16 Thousand |
| Investing Cash Flow | -2.1 Million | 1.16 Million | -165.35 Thousand | -1.83 Million | -895 Thousand | - |
| Investments in PPE | - | -74 Thousand | -116.97 Thousand | -167.45 Thousand | -95 Thousand | - |
| Acquisitions | - | - | 116.97 Thousand | -410 Thousand | - | - |
| Investment purchases | - | - | -2.55 Million | -2.3 Million | -800 Thousand | - |
| Sales/Maturities of investments | - | 1.23 Million | 2.5 Million | 1.08 Million | - | - |
| Other Investing Activities | - | 1161.70 | -116.97 Thousand | -50 Thousand | -895.00 | - |
| Financing Cash Flow | 11.31 Million | 6.03 Million | 18.19 Million | 8.72 Million | 7.45 Million | 1.15 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -10.00 | - | - | - | 132.16 Thousand |
| Common Stock Issuance | 11.31 Million | 5.98 Million | 17.83 Million | 8.66 Million | 7.45 Million | 1.18 Million |
| Other Financing Activities | 2355.00 | 51 Thousand | 359.51 Thousand | 56.25 Thousand | 163.00 | -163.67 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -700.75 Thousand | 590.63 Thousand | 535.34 Thousand | -151.98 Thousand | 267.35 Thousand | 94.35 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -47.3 Thousand | 3847.00 | -5420.00 | 20.23 Thousand | -97.71 Thousand | -13.89 Thousand |
| Cash at beginning of period | 8.53 Million | 8.53 Million | 2.62 Million | 1.89 Million | 282.62 Thousand | 1.23 Million |
| Cash at end of period | 9.29 Million | 6.42 Million | 8.53 Million | 2.62 Million | 1.89 Million | 282.62 Thousand |
| Capital Expenditure | - | -74 Thousand | -116.97 Thousand | -167.45 Thousand | -95 Thousand | - |
| Effect of forex changes on cash | -6518.00 | -9593.00 | -30.56 Thousand | -15.35 Thousand | - | - |
| Net cash flow / Change in cash | 754.08 Thousand | -2.1 Million | 5.9 Million | 738.8 Thousand | 1.6 Million | -947.81 Thousand |
| Free Cash Flow | -8.44 Million | -9.37 Million | -12.2 Million | -6.3 Million | -5.04 Million | -2.1 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.63 Million | -2.04 Million | -7.84 Million | -1.7 Million | -2.08 Million | -1.87 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 7054.00 | 513.35 Thousand | 216.42 Thousand | 5785.00 | 190.26 Thousand | 9748.00 |
| Change in working capital | 33.69 Thousand | -197.1 Thousand | -748.05 Thousand | -1.14 Million | 293.48 Thousand | 247.01 Thousand |
| Other non-cash items | -33.18 Thousand | 553.23 Thousand | -70.08 Thousand | -229.83 Thousand | -33.75 Thousand | 166.57 Thousand |
| Investing Cash Flow | - | - | -2.1 Million | -1.00 | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -1.00 | - | - |
| Financing Cash Flow | 3.68 Million | - | 11.31 Million | - | 2.4 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.68 Million | - | 11.31 Million | - | 2.4 Million | - |
| Other Financing Activities | 3.68 Million | - | 2355.00 | - | 495.00 | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 40.24 Thousand | -39.3 Thousand | -700.75 Thousand | -1.23 Million | 207.18 Thousand | 378.15 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -6548.00 | -157.79 Thousand | -47.3 Thousand | 93.78 Thousand | 86.3 Thousand | -131.14 Thousand |
| Cash at beginning of period | 7.56 Million | 9.29 Million | 8.53 Million | 11.82 Million | 11.54 Million | 13.04 Million |
| Cash at end of period | 9.65 Million | 7.56 Million | 9.29 Million | 9.29 Million | 11.82 Million | 11.54 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 1634.00 | -5768.00 | -6518.00 | 535.5 Thousand | -485.94 Thousand | -49.88 Thousand |
| Net cash flow / Change in cash | 2.09 Million | -1.72 Million | 754.08 Thousand | -2.53 Million | 283.44 Thousand | -1.49 Million |
| Free Cash Flow | -1.59 Million | -1.72 Million | -8.44 Million | -3.07 Million | -1.63 Million | -1.44 Million |
601872
ABEV
ATULAUTO
CLNE
SMT
3941